When a tumor develops in an organism, it is very common for the cancer cells to leave the tumor and settle in another organ where they proliferate, creating what is called metastasis. This process is an important factor in mortality since it means the worsening of the disease. Hence the interest in better understanding what happens during this phenomenon. This is what the multidisciplinary team of Carine Michiels, researcher at the NARILIS Institute of UNamur, and Davide Bonifazi, researcher at the University of Vienna, did in the framework of the PACMAN research project funded by the FNRS. The results of this study are published in the journal Neoplasia.
In a large epidemiological study researchers from KU Leuven show that patients with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease than individuals without autoimmune disease.
Postdoctoral researcher Inverse problems and computational imaging Universiteit Antwerpen
Doctoral scholarship holder Primary Care Universiteit Antwerpen
Postdoc position in Computational genomics of Alzheimer’s disease Universiteit Antwerpen
Doctoral scholarship holder in Advanced Artificial Intelligence Universiteit Antwerpen
Postdoctoral researcher Medicinal chemistry and proline-specific proteases Universiteit Antwerpen
Doctoral scholarship holder Electrocatalysis in an European grant Threading Universiteit Antwerpen
Doctoral scholarship holder Urban logistics Universiteit Antwerpen
Doctoral scholarship holder Sustainable mobility Universiteit Antwerpen
Vrije Universiteit Brussel establishes Caroline Pauwels Academy of Critical Thinking
Vrije Universiteit Brussel Academic Opening: 'Science as a Public Good'
RHEA Luxembourg leads international partnership with ESA on QKD
VUB professor Elvira Haezendonck elected president IAME
VUB continues to grow: popularity of languages and sciences on the rise
EIC Pathfinder grant for research in AI-driven data visualisation
VUB Academic Opening: Science as a Public Good
Ghent University and VIB open new research building with unique BioSafety Level 3 facility for airborne pathogens
Sibel Ügdüler wins the Eos Pipet 2022
KU Leuven spin-off AstriVax raises ¤30 million to build vaccine platform